SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006883
Filing Date
2017-08-31
Accepted
2017-08-31 16:06:45
Documents
72
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20170630x10q.htm 10-Q 2115488
2 EX-31.1 kala-20170630ex311770434.htm EX-31.1 21344
3 EX-31.2 kala-20170630ex312312a87.htm EX-31.2 21337
4 EX-32.1 kala-20170630ex32166fc0e.htm EX-32.1 9012
5 EX-32.2 kala-20170630ex322e2c6a1.htm EX-32.2 9424
  Complete submission text file 0001558370-17-006883.txt   7926277

Data Files

Seq Description Document Type Size
6 EX-101.INS kala-20170630.xml EX-101.INS 1853228
7 EX-101.SCH kala-20170630.xsd EX-101.SCH 43348
8 EX-101.CAL kala-20170630_cal.xml EX-101.CAL 35295
9 EX-101.DEF kala-20170630_def.xml EX-101.DEF 209190
10 EX-101.LAB kala-20170630_lab.xml EX-101.LAB 390649
11 EX-101.PRE kala-20170630_pre.xml EX-101.PRE 349630
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 171063464
SIC: 2834 Pharmaceutical Preparations